List of works - Piotr Ozierański

A pill too hard to swallow: how the NHS is limiting access to high priced drugs.

scientific article published on 27 July 2016

A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding

scientific article published in 2021

Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review

scientific article published on 16 December 2021

Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology

scientific article published on 20 May 2019

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

scientific article published on 05 June 2019

Culture and behaviour in the English National Health Service: overview of lessons from a large multimethod study.

scientific article published on 09 September 2013

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts

article

Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

scientific article published on 19 August 2019

Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’ Self‐Citation Rate in Jap

Exposing drug industry funding of UK patient organisations.

scientific article published on 22 May 2019

How collaborative are quality improvement collaboratives: a qualitative study in stroke care

scientific article published on 11 March 2014

How not to waste a crisis: a qualitative study of problem definition and its consequences in three hospitals

scientific article published on 01 March 2019

Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016

scientific article published on 08 June 2019

Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?

scientific article published on 08 August 2011

Running a hospital patient safety campaign: a qualitative study

scientific article published on January 2014

Shedding light on the HTA consultancy market: Insights from Poland

scientific article published on 20 August 2019

The persistence of cliques in the post-communist state. The case of deniability in drug reimbursement policy in Poland

scientific article published on 21 May 2016

The politics of health technology assessment in Poland

article

The whistleblowing drama behind Astellas's suspension from the ABPI

scientific article published on 02 July 2019

Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.

scientific article published on 8 January 2018

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)

scientific article published on 19 September 2020

Wales approves new hepatitis C drug while England deliberates

scientific article published on 01 December 2016

Walkrounds in practice: corrupting or enhancing a quality improvement intervention? A qualitative study

scientific article published on July 2014

When health technology assessment is confidential and experts have no power: the case of Hungary

scientific article

List of works by Piotr Ozierański